Authors
Jonathan Sharp serves as the Chief Financial Officer at Environmental Litigation Group, P.C., where he oversees case evaluation, financial analysis, and asset management. Based in Birmingham, Alabama, the firm specializes in assisting victims of toxic exposure, with a primary focus on supporting both civilian and military firefighters.
Isabella Ciccone, assistant editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter at @iciccone7 or email her at iciccone@mjhlifesciences.com.
Weston Blakeslee, PhD, is the vice president of clinical strategy at DrFirst.
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5

